Literature DB >> 7931083

A pathway for entry of reoviruses into the host through M cells of the respiratory tract.

M J Morin1, A Warner, B N Fields.   

Abstract

Many microorganisms gain access to the systemic circulation after entering the respiratory tract. The precise pathways used to cross the mucosal barriers of the lungs have not been clearly described. We have used the mammalian reoviruses in order to determine the pathway that a systemic virus uses to penetrate the mucosal barrier and enter the systemic circulation after entering the airways of the lungs. Reoviruses enter through pulmonary M cells, which overlie bronchus-associated lymphoid tissue, and subsequently spread to regional lymph nodes. Thus, the pathway through M cells represents a strategy by which viruses and probably other microorganisms can penetrate the mucosal surface of the respiratory tract and thereby enter the systemic circulation.

Entities:  

Mesh:

Year:  1994        PMID: 7931083      PMCID: PMC2191676          DOI: 10.1084/jem.180.4.1523

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Bronchial lymphoepithelial nodules in the rat: morphologic features and uptake and transport of exogenous proteins.

Authors:  M Fournier; F Vai; J P Derenne; R Pariente
Journal:  Am Rev Respir Dis       Date:  1977-10

2.  Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3.

Authors:  R F Ramig; R K Cross; B N Fields
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

3.  Uptake and transport of horseradish peroxidase by lymphoepithelium of the bronchus-associated lymphoid tissue in normal and bacillus Calmette-Guérin-immunized and challenged rabbits.

Authors:  K Tenner-Rácz; P Rácz; Q N Myrvik; J R Ockers; R Geister
Journal:  Lab Invest       Date:  1979-08       Impact factor: 5.662

Review 4.  The role of the pulmonary lymphatics in the defenses of the distal lung: morphological and experimental studies of the transport mechanisms of intratracheally instillated particles.

Authors:  J M Lauweryns; J H Baert
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

5.  Ultrastructure of the pulmonary lymphoid tissue.

Authors:  D W Chamberlain; C Nopajaroonsri; G T Simon
Journal:  Am Rev Respir Dis       Date:  1973-09

6.  Intestinal M cells: a pathway for entry of reovirus into the host.

Authors:  J L Wolf; D H Rubin; R Finberg; R S Kauffman; A H Sharpe; J S Trier; B N Fields
Journal:  Science       Date:  1981-04-24       Impact factor: 47.728

7.  The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice.

Authors:  R S Kauffman; J L Wolf; R Finberg; J S Trier; B N Fields
Journal:  Virology       Date:  1983-01-30       Impact factor: 3.616

8.  Changes in gut-associated lymphoid tissues of the small intestine of eight-week-old pigs infected with transmissible gastroenteritis virus.

Authors:  R M Chu; R D Glock; R F Ross
Journal:  Am J Vet Res       Date:  1982-01       Impact factor: 1.156

9.  Development of bronchus associated lymphoid tissue (BALT) in the rat, with special reference to T- and B-cells.

Authors:  B E Plesch; G J Gamelkoorn; M van de Ende
Journal:  Dev Comp Immunol       Date:  1983       Impact factor: 3.636

10.  Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine.

Authors:  J L Wolf; R S Kauffman; R Finberg; R Dambrauskas; B N Fields; J S Trier
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

View more
  19 in total

Review 1.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 2.  The immunopathology of M cells.

Authors:  I C Davis; R L Owen
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Respiratory mucosal immunization with reovirus serotype 1/L stimulates virus-specific humoral and cellular immune responses, including double-positive (CD4(+)/CD8(+)) T cells.

Authors:  S B Periwal; J J Cebra
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Ultrastructural study on the follicle-associated epithelium of nasal-associated lymphoid tissue in specific pathogen-free (SPF) and conventional environment-adapted (SPF-CV) rats.

Authors:  K I Jeong; H Suzuki; H Nakayama; K Doi
Journal:  J Anat       Date:  2000-04       Impact factor: 2.610

5.  Expression of endothelia and lymphocyte adhesion molecules in bronchus-associated lymphoid tissue (BALT) in adult human lung.

Authors:  Nakaaki Kawamata; Baohui Xu; Hiroo Nishijima; Kohji Aoyama; Mayumi Kusumoto; Toru Takeuchi; Chuwa Tei; Sara A Michie; Takami Matsuyama
Journal:  Respir Res       Date:  2009-10-22

6.  In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection.

Authors:  Laurent Gillet; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

7.  Reovirus infection in rat lungs as a model to study the pathogenesis of viral pneumonia.

Authors:  M J Morin; A Warner; B N Fields
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Reovirus preferentially infects the basolateral surface and is released from the apical surface of polarized human respiratory epithelial cells.

Authors:  Katherine J D A Excoffon; Kristen M Guglielmi; J Denise Wetzel; Nicholas D Gansemer; Jacquelyn A Campbell; Terence S Dermody; Joseph Zabner
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

Review 9.  Lymphocytes in the lung: an often neglected cell. Numbers, characterization and compartmentalization.

Authors:  R Pabst; T Tschernig
Journal:  Anat Embryol (Berl)       Date:  1995-10

10.  Respiratory infection of mice with mammalian reoviruses causes systemic infection with age and strain dependent pneumonia and encephalitis.

Authors:  Lianne Gauvin; Steffany Bennett; Hong Liu; Mansoureh Hakimi; Michael Schlossmacher; Jay Majithia; Earl G Brown
Journal:  Virol J       Date:  2013-03-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.